ncRNA name
hsa-miR-205-5p
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
PTEN/JNK/ANXA3 signaling pathway
Cancer name
Hepatocellular Carcinoma
Cancer site
Liver
Treatment type
Chemotherapy
Drug
5-Fluorouracil
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Down
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Inhibition of miR-205-5p may reverse chemotherapeutic resistance to 5-Fu, and this may occur via the PTEN/JNK/ANXA3 pathway.
Tissue resource
normal liver cell lines LO2
hepatoma cell lines Bel-7402
hepatoma cell lines SMMC-7721
hepatoma cell lines HCCLM3
hepatoma cell lines MHCC97-H
hepatoma cell lines MHCC97-L
hepatoma cell lines Huh-7
Experiment
qRT-PCR,Western blot
Institute
KeyGen Biotech Co., Ltd.
the Second Affiliated Hospital of Dalian Medical University
Country
China
Continent
Asia